# Efficacy and Safety of Etanercept in Active RA Despite Methotrexate Therapy in Japan

> **NCT00688103** · PHASE4 · COMPLETED · sponsor: **Japan Biological Agent Study Integrated Consortium** · enrollment: 151 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** ETN Alone
- **DRUG:** ETN+MTX

## Key facts

- **NCT ID:** NCT00688103
- **Lead sponsor:** Japan Biological Agent Study Integrated Consortium
- **Sponsor class:** NETWORK
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-06
- **Primary completion:** 2008-10
- **Final completion:** 2010-10
- **Target enrollment:** 151 (ACTUAL)
- **Last updated:** 2015-10-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00688103

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00688103, "Efficacy and Safety of Etanercept in Active RA Despite Methotrexate Therapy in Japan". Retrieved via AI Analytics 2026-06-07 from https://api.ai-analytics.org/clinical/NCT00688103. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*